Safety in Japanese Advanced Breast Cancer Patients Who Received Abemaciclib in MONARCH 2 and MONARCH 3: Assessment of Treatment-Emergent Neutropenia, Diarrhea, and Increased Alanine Aminotransferase and Aspartate Aminotransferase Levels

PURPOSE: Our objective was to gain a better understanding of the safety of abemaciclib in Japanese patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer. PATIENTS AND METHODS: Treatment-emergent adverse events (TEAEs) were assessed in poole...

Descripción completa

Detalles Bibliográficos
Autores principales: Masuda, Norikazu, Chen, Yucherng, Kawaguchi, Tsutomu, Dozono, Koji, Toi, Masakazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943964/
https://www.ncbi.nlm.nih.gov/pubmed/35342308
http://dx.doi.org/10.2147/CMAR.S348591

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943964/
https://www.ncbi.nlm.nih.gov/pubmed/35342308
http://dx.doi.org/10.2147/CMAR.S348591

Ejemplares similares